[1] WEBSTER AC, NAGLER EV, MORTON RL, et al. Chronic kidney disease[J]. Lancet, 2017, 389(10075): 1238. doi: 10.1016/S0140-6736(16)32064-5
[2] DISTHABANCHONG S, SRISUWARN P. Mechanisms of vascular calcification in kidney disease[J]. Adv Chronic Kidney Dis, 2019, 26(6): 417. doi: 10.1053/j.ackd.2019.08.014
[3] LX, CAO F, LIU S, MI Y, et al. BMP2/Smad signaling pathway is involved in the inhibition function of fibroblast growth factor 21 on vascular calcification[J]. Biochem Biophys Res Commun, 2018, 503(2): 930. doi: 10.1016/j.bbrc.2018.06.098
[4] YUAN C, NI L, ZHANG C, et al. Vascular calcification: New insights into endothelial cells[J]. Microvasc Res, 2021, 134: 104105. doi: 10.1016/j.mvr.2020.104105
[5] SALGADO JV, GOES MA, SALGADO FILHO N. FGF21 and Chronic Kidney Disease[J]. Metabolism, 2021, 118: 154738. doi: 10.1016/j.metabol.2021.154738
[6] ZHANG F, YU L, LIN X, et al. Minireview: roles of fibroblast growth factors 19 and 21 in metabolic regulation and chronic diseases[J]. Mol Endocrinol, 2015, 29(10): 1400. doi: 10.1210/me.2015-1155
[7] GAMROT Z, ADAMCZYK P, SWIETOCHOWSKA E, et al. Fibroblast growth factor 21(FGF21) in children and adolescents with chronic kidney disease[J]. Physiol Res, 2020, 69(3): 451.
[8] ANUWATMATEE S, TANG S, WU BJ, et al. Fibroblast growth factor 21 in chronic kidney disease[J]. Clin Chim Acta, 2019, 489: 196. doi: 10.1016/j.cca.2017.11.002
[9] SUASSUNA PGA, DE PAULA RB, SANDERS-PINHEIRO H, et al. Fibroblast growth factor 21 in chronic kidney disease[J]. J Nephrol, 2019, 32(3): 365. doi: 10.1007/s40620-018-0550-y
[10] OLAPOJU SO, ADEJOBI OL, LE THI X. Fibroblast growth factor 21;review on its participation in vascular calcification pathology[J]. Vascul Pharmacol, 2020, 125(126): 106636.
[11] SHI Y, WANG S, PENG H, et al. Fibroblast growth factor 21 attenuates vascular calcification by alleviating endoplasmic reticulum stress mediated apoptosis in rats[J]. Int J Biol Sci, 2019, 15(1): 138. doi: 10.7150/ijbs.28873
[12] SHI Y, LU W, HOU Y, et al. Fibroblast growth factor 21 ameliorates vascular calcification by inhibiting osteogenic transition in vitamin D3 plus nicotine treated rats[J]. Biochem Biophys Res Commun, 2018, 495(4): 2448. doi: 10.1016/j.bbrc.2017.10.115
[13] CAO F, LIU X, CAO X, et al. Fibroblast growth factor 21 plays an inhibitory role in vascular calcification in vitro through OPG/RANKL system[J]. Biochem Biophys Res Commun, 2017, 491(3): 578. doi: 10.1016/j.bbrc.2017.07.160
[14] CAO F, WANG S, CAO X, et al. Fibroblast growth factor 21 attenuates calcification of vascular smooth muscle cells in vitro[J]. J Pharm Pharmacol, 2017, 69(12): 1802. doi: 10.1111/jphp.12826
[15] HAN Y, JIN SW, LEE GH, et al. Stimulatory effects of platycodin D on osteoblast differentiation[J]. J Cell Biochem, 2019, 120(8): 13085. doi: 10.1002/jcb.28580
[16] WU YT, HSU BG, WANG CH, et al. Lower serum fibroblast growth factor 21 levels are associated with normal lumbar spine bone mineral density in hemodialysis patients[J]. Int J Environ Res Public Health, 2020, 17(6): 1938. doi: 10.3390/ijerph17061938
[17] LOWERY JW, ROSEN V. The BMP pathway and its inhibitors in the skeleton[J]. Physiol Rev, 2018, 98(4): 2431.
[18] QIU WX, MA XL, LIN X, et al. Deficiency of Macf1 in osterix expressing cells decreases bone formation by Bmp2/Smad/Runx2 pathway[J]. J Cell Mol Med, 2020, 24(1): 317.
[19] WEI X, WU W, LI L, et al. Bone morphogenetic proteins 2/4 are upregulated during the early development of vascular calcification in chronic kidney disease[J]. Biomed Res Int, 2018, 2018: 8371604.
[20] WILLEMS BA, FURMANIK M, CARON MMJ, et al. Ucma/GRP inhibits phosphate-induced vascular smooth muscle cell calcification via SMAD-dependent BMP signalling[J]. Sci Rep, 2018, 8(1): 4961. doi: 10.1038/s41598-018-23353-y